Latest Ketones Stories

The American Society of Addiction Medicine (ASAM) will release the most comprehensive report on the effectiveness of medications for opiate addiction and on the arbitrary restrictions on these FDA-approved drugs by many state governments and insurance companies. Safe and effective medications to treat opiate addiction are seriously under-utilized, resulting in preventable suffering and death. Washington (PRWEB) June 17, 2013 The American Society of Addiction Medicine (ASAM) will release...

Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say may be fueled by misguided concern by patients and their caregivers. Calling the rate of missed doses "unacceptably high," the researchers add that hospitalized patients are at a significantly greater risk of developing venous thromboembolism, or VTE, and that...

Oxycodone is mostly used as pain medication, yet it can become habit forming. Recovery Associates’ therapists, counselors and programs help individuals heal from addictive ways. West Palm Beach, FL (PRWEB) June 12, 2013 Oxycodone is a medication that provides relief to individuals suffering from moderate to severe pain symptoms. It has been known to lead people down an addictive path – one that leaves them wanting more medication. Oxycodone is an opioid pain medication, and an opioid...

PENNINGTON, New Jersey, June 12, 2013 /PRNewswire/ -- Zydus Pharmaceuticals USA Inc. is voluntarily recalling one lot of Warfarin 2 mg Tablets, Lot # MM5767, expiration date June 2014 to the retail level. Four tablets of Warfarin 2 mg Tablets, Lot MM5767, have been found to be oversized in one product complaint. Ingestion of a greater than intended dose of Warfarin, could lead to an increased pharmacological effect of warfarin. As a result, patients would be more likely...

Composition of Matter Patent Provides Coverage Until 2031 SYDNEY and BEDMINSTER, N.J., June 12, 2013 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the Company U.S. Patent #8,461,171 ("'171 patent") titled "Hybrid Opioid Compounds and Compositions," which expires in 2031. This patent covers a hybrid morphine-oxycodone molecule where these two different opioids are chemically linked. The...

PISGAH FOREST, N.C., June 12, 2013 /PRNewswire/ -- As controversy surrounds the recent FDA decisions concerning abuse deterrent forms of oxycodone drug products, Pisgah Laboratories, Inc. (www.pisgahlabs.com) achieves another technical milestone which may radically alter the landscape for pain medication regulations. Recently, the FDA ruled that the Abbreviated New Drug Applications (ANDAs) -- competitive to Purdue Pharma's branded Oxycodone® -- would no longer be considered if they...

WASHINGTON, June 11, 2013 /PRNewswire-USNewswire/ -- The Center for Lawful Access and Abuse Deterrence (CLAAD) joined in signing a Citizen Petition filed today urging the Food and Drug Administration (FDA) to fully implement the Obama administration's policy supporting a market transition to safer opioid medications. The petition asks that the FDA reject applications for new opioid medications without added safety features. Opioids are a class of synthetically derived chemicals often...

New findings provide vital step towards exploring pain medications that may lower risks of prescription drug abuse and side effects of painkillers For patients managing cancer and other chronic health issues, painkillers such as morphine and Vicodin are often essential for pain relief. The body's natural tendency to develop tolerance to these medications, however, often requires patients to take higher doses – increasing risks of harmful side effects and dependency. Now, new research...

NORTH LIBERTY, Iowa, June 11, 2013 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,461,137 to KemPharm for its patent application entitled, "Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use...

Raspberry Ketones Extracts and Green Coffee Bean Extracts in one single supplement "Ketone Balance" to provide a highly effective formula to boost the weight loss process naturally LOS ANGELES, June 11, 2013 /PRNewswire/ -- Ketone Balance duo, the latest innovation in the weight loss industry, is recently launched by a UK based company, Evolution Slimming. Since its arrival in the market, the product has become the major buzz in the media for its unique formulation which combines two...